Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
ADMA Biologics Inc (ADMA) had Weighted-Average Shares Outstanding (Diluted) of 244.68M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$114.80M |
|
$26.90M |
|
$53.70M |
|
$61.10M |
|
$79.92M |
|
$34.88M |
|
$-1.43M |
|
$33.45M |
|
$33.45M |
|
$26.90M |
|
$26.90M |
|
$26.90M |
|
$26.90M |
|
$34.88M |
|
$37.00M |
|
237.78M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
244.68M |
$0.11 |
|
$0.11 |
|
| Balance Sheet Financials | |
$351.81M |
|
$57.71M |
|
$158.75M |
|
$510.57M |
|
$53.50M |
|
$80.83M |
|
$83.65M |
|
$137.15M |
|
$373.42M |
|
$369.44M |
|
$373.42M |
|
238.53M |
|
| Cash Flow Statement Financials | |
$-19.68M |
|
$-4.72M |
|
$-7.13M |
|
$103.15M |
|
$71.62M |
|
$-31.52M |
|
$4.62M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.58 |
|
-- |
|
-- |
|
0.18 |
|
0.22 |
|
53.22% |
|
30.38% |
|
30.38% |
|
-- |
|
29.14% |
|
23.44% |
|
$-24.38M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
0.31 |
|
1.15 |
|
77.93 |
|
7.20% |
|
7.28% |
|
5.27% |
|
5.92% |
|
$1.57 |
|
$-0.10 |
|
$-0.08 |
|